Rights and permissions
About this article
Cite this article
ASCO’s “top five“ costly overused interventions. Pharmacoecon. Outcomes News 652, 2 (2012). https://doi.org/10.2165/00151234-201206520-00003
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-201206520-00003